Journey Medical Corporation

NASDAQ:DERM

3.73 (USD) • At close January 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q4
Revenue 14.62914.85513.0315.25734.53917.17212.21315.96616.11618.29123.29617.51719.6115.28810.71913.7239.4479.41510.68111.53366.6452.4522.2430.71739.080.2991.3431.0661.0661.06622.4660.119007.37.3007.3
Cost of Revenue 5.2856.5416.8166.0156.4297.7676.4497.7187.2217.6338.2039.52511.1677.4843.9084.2813.3793.1243.4671.9321.3350.9260.9390.237000000000000000
Gross Profit 9.3448.3146.2149.24228.119.4055.7648.2488.89510.65815.0937.9928.4437.8046.8119.4426.0686.2917.2149.60165.311.5261.3040.4839.080.2991.3431.0661.0661.06622.4660.119007.37.3007.3
Gross Profit Ratio 0.6390.560.4770.6060.8140.5480.4720.5170.5520.5830.6480.4560.4310.510.6350.6880.6420.6680.6750.8320.980.6220.5810.669111111110011001
Reseach & Development Expenses 0.8420.9137.8841.5052.2291.7742.0334.2562.8122.6091.2661.9920.79413.7720000018.41618.28515.56919.11916.29219.54525.59127.78330.78825.97819.8620.8617.78421.66822.85424.35818.8913.49510.08811.034
General & Administrative Expenses 00012.141012.14100015.19100000000046.35663.32748.67951.79149.5140.7730.5127.23619.75413.58711.3269.4938.2766.3735.9015.0434.6843.8484.1463.048
Selling & Marketing Expenses 000-2.3000000000000000-0000.891001.1260128.5550000002.3940000
SG&A 11.39610.3288.429.8418.63612.14113.29213.98715.57515.19114.71515.05710.7557.7956.2265.8165.8294.7525.22146.35663.32748.67952.68249.5140.7731.63627.236148.30913.58711.3269.4938.2766.3735.9017.4374.6843.8484.1463.048
Other Expenses 000-0.81503.1430000045.9039.540000000002.017001.126128.555128.55500000000000
Operating Expenses 12.23811.24116.30411.34610.86513.91515.32518.24318.38717.815.98117.04911.54921.5676.2265.8165.8294.7525.2264.77281.61264.24871.80165.80260.31557.22755.019179.09739.56531.18630.35326.0628.04128.75531.79523.57417.34314.23414.082
Operating Income -2.894-2.927-10.09-2.10417.245-7.653-9.561-9.995-9.492-7.142-0.91-9.32-12.646-13.7630.5853.6260.2391.5391.993-55.171-16.302-62.722-70.497-65.322-21.235-56.928-53.676-178.031-38.499-30.12-7.887-25.941-56.796-28.755-79.646-16.274-31.577-14.23424.916
Operating Income Ratio -0.198-0.197-0.774-0.1380.499-0.446-0.783-0.626-0.589-0.39-0.039-0.532-0.645-0.90.0550.2640.0250.1630.187-4.784-0.245-25.58-31.43-91.105-0.543-190.395-39.967-167.008-36.115-28.255-0.351-217.99200-10.91-2.229003.413
Total Other Income Expenses Net 0.504-0.434-0.3520.087-0.361-0.71-0.575-0.634-0.578-0.45-0.386-4.359-1.375-1.524-0.221-0.206-0.187-0.155-0.153-2.45-1.66-2.11-1.313-1.222-2.697-2.326-2.336-1.143-0.0670.6110.5040.4310.6050.319-61.460.22-13.8510.199-31.612
Income Before Tax -2.39-3.361-10.442-2.01716.884-8.363-10.136-10.629-10.07-7.592-1.274-13.416-14.021-15.2870.3643.420.0521.3841.841-57.621-17.962-64.832-71.81-66.544-23.932-59.254-56.012-179.174-38.566-29.509-7.383-25.51-56.191-28.436-79.021-16.054-31.194-14.035-6.696
Income Before Tax Ratio -0.163-0.226-0.801-0.1320.489-0.487-0.83-0.666-0.625-0.415-0.055-0.766-0.715-10.0340.2490.0060.1470.172-4.996-0.27-26.44-32.015-92.809-0.612-198.174-41.707-168.081-36.178-27.682-0.329-214.3700-10.825-2.19900-0.917
Income Tax Expense 000.7930.1260.095-2.466-0.0750.0130.01-0.0640.1048.335-3.375-3.4220.0960.9180.0230.9290.4651.9481.971.551-0.1942.1982.037-0.1941.621.7211.2530.6110.5040.4310.6050.319-0.6220.2590.4210.2370.031
Net Income -2.39-3.361-10.442-2.14316.789-8.363-10.061-10.642-10.08-7.528-1.378-21.751-10.646-11.8650.2682.5020.0290.4551.376-57.621-17.962-64.832-71.81-66.544-23.932-59.254-56.012-179.174-38.566-29.509-7.383-25.51-56.191-28.436-78.399-16.054-31.194-14.035-6.727
Net Income Ratio -0.163-0.226-0.801-0.140.486-0.487-0.824-0.667-0.625-0.412-0.059-1.242-0.543-0.7760.0250.1820.0030.0480.129-4.996-0.27-26.44-32.015-92.809-0.612-198.174-41.707-168.081-36.178-27.682-0.329-214.3700-10.74-2.19900-0.922
EPS -0.12-0.17-0.53-0.110.91-0.46-0.56-0.6-0.57-0.43-0.08-1.64-1.16-1.30.0290.150.0030.0280.13-1.06-0.33-1.49-1.7-1.58-0.47-1.17-1.1-3.53-0.76-0.58-0.15-0.5-1.11-0.56-1.55-0.32-0.61-0.28-0.13
EPS Diluted -0.12-0.17-0.53-0.110.8-0.46-0.56-0.6-0.57-0.43-0.08-1.64-1.16-1.30.0290.150.0030.0280.13-1.06-0.33-1.49-1.7-1.58-0.47-1.17-1.1-3.53-0.76-0.79-0.22-0.79-1.84-0.95-2.93-0.63-1.26-0.57-0.27
EBITDA -0.795-1.959-9.058-1.15517.988-6.517-8.395-8.764-8.472-6.0990.154-8.829-11.968-13.0011.1693.9820.6181.5392.35-53.081-14.188-61.021-68.422-62.726-16.569-53.26-52.524-175.516-36.931-29.428-7.348-24.688-56.535-28.826-79.469-16.531-31.664-14.433-6.83
EBITDA Ratio -0.054-0.132-0.71-0.0830.5-0.258-0.684-0.623-0.524-0.3330.006-0.517-0.158-0.850.1110.2920.0650.1630.22-4.603-0.213-24.886-30.505-87.484-0.424-178.127-39.109-164.649-34.644-27.606-0.327-207.46200-10.886-2.26500-0.936